Companies /Consumer Defensive
Altria Group Inc
NYSE: MO Tobacco
$76.12
▼ $1.46 (−1.88%) today
Markets closed · 10:44pm ET

Altria (MO) Q3 2026 Earnings

Reported Oct 29, 2026, 7:04am ET · SEC source
$1.52
Beat +0.70%
EPS · est. $1.51 Adjusted
$5.4B
Beat +2.46%
Revenue · est. $5.3B
1 quarter
Consecutive EPS beats

How Did MO Stock React to Q3 2026 Earnings?

% change · around the report
−4%0+4%Oct 29Oct 30report 7:04am ETearnings−4.1%+5.8%
−4%0+4%Oct 29Oct 30earnings−4.1%+5.8%
MO +5.8%NASDAQ −4.1%
−10%−5%0+5%Oct 28Nov 6report 7:04am ETearnings−8.4%+1.5%
−10%−5%0+5%Oct 28Nov 6earnings−8.4%+1.5%
MO +1.5%NASDAQ −8.4%
+5.15%
Day of report
+1.67%
Next session
+1.08%
One week

Did MO Beat Earnings? Q3 2026 Results

Yes. Altria reported Q3 2026 earnings of $1.52 a share on Oct 29, 2026, beating the $1.51 consensus estimate by 0.7%. Revenue was $5.4B against a $5.3B estimate.

Altria Group posted a solid third quarter, beating Wall Street expectations on both the top and bottom lines as pricing power and a surge in equity income from AB InBev more than offset persistent volume headwinds. Adjusted EPS came in at $1.52, edging past the $1.51 consensus estimate by 0.70%, while revenue of $5.44 billion topped forecasts of $5.31 billion by 2.46% and grew 3.6% year over year. The most material driver beneath those headline numbers was a sharp jump in ABI equity income, which rose to $228 million from $123 million a year earlier, providing meaningful lift to both reported and adjusted earnings. Within operations, the smokeable products segment carried its weight, with adjusted OCI margins reaching 64.5% on higher pricing and favorable tax refunds on imported cigarettes, even as domestic cigarette shipments fell an estimated 4% on an adjusted basis. Oral tobacco remained a soft spot, with segment adjusted OCI down 3.7% and pouch brand on! losing 1.3 points of share in the nicotine pouch category. Looking ahead, Altria raised its full-year adjusted diluted EPS guidance to $5.66 to $5.74, representing 4.5% to 6.0% growth from its 2025 base.

Key Takeaways
  • Higher smokeable pricing and higher refunds of taxes and duties on imported cigarettes lifted smokeable adjusted OCI 3.9%
  • Higher adjusted earnings from ABI investment (ABI equity income $228M vs $123M)
  • Domestic cigarette shipments down 2.9% (down an estimated 4% adjusted for trade inventory); industry volume down an estimated 5%
  • Discount cigarette shipments up 40.5% while Marlboro shipments fell 6.4%
  • Oral tobacco adjusted OCI down 3.7% on lower volume, higher costs and promotional investments
  • Copenhagen volume down 10.1% and Skoal down 12.6%; on! volume up 13.3%
  • Contract manufactured export cigarette volume rose to 1,595 million sticks from 311 million

“Altria delivered strong financial performance in the third quarter, growing adjusted diluted earnings per share by 4.8%, while continuing to invest in our Vision and building on our foundation for the future.”

Altria CEO, on the earnings call

What Is Altria's Outlook?

Altria raised its 2026 full-year adjusted diluted EPS guidance to $5.66–$5.74, representing 4.5% to 6.0% growth from a 2025 base of $5.42. The guidance contemplates: - moderated e-vapor industry growth affecting combustible and e-vapor volumes; - increased macroeconomic uncertainty for adult nicotine consumers; - investments in contract manufacturing capabilities; - NJOY ACE not returning to market in 2026; - reinvestment of Optimize & Accelerate cost savings; - investments supporting its Vision. Altria maintains its goal of mid-single-digit annual dividend per share growth through 2028. Helix plans to launch on! PLUS Watermelon Mint in select retail locations in Q4.

MO YoY Financials

Q3 2026 vs Q3 2025 · SEC filings Q3 2025 Q3 2026
$0$2.0B$4.0B$5.3B$5.4BRevenue$3.8B$3.9BGross Profit$3.2B$3.3BOperating Income$2.4B$2.5BNet Income
$0$2.0B$4.0BRevenueGross ProfitOperating IncomeNet Income
MO income statement, Q3 2026 versus Q3 2025
Metric Q3 2026 Q3 2025 Year over year
Revenue $5.4B $5.3B +3.6%
Gross Profit $3.9B $3.8B +3.4%
Operating Income $3.3B $3.2B +2.6%
Net Income $2.5B $2.4B +6.0%

MO Revenue by Segment

Smokeable Products$5.4B+0.8%
Oral Tobacco Products$688.0M−0.1%
E-Vapor Products

When Does Altria Report Next?

Expected report date
After the close
Release timing

Figures from SEC filings and company reports. Not investment advice.